The major U.S. equity indexes weren't the only ones making history on Tuesday. » Read More
Momenta says Pfizer, a key supplier for its multiple sclerosis drug, has received a warning letter from the Food and Drug Administration. » Read More
Vanguard founder and former CEO Jack Bogle shares his views on the market.
Two popular biotech exchange-traded funds have been on a tear lately, and some strategists see more upside ahead.
Despite a rally that has sent the S&P 500 up a gaudy 5 percent, Goldman is sticking to its fairly pessimistic call for the full year.
Macy's CEO Terry Lundgren sat down with CNBC for an exclusive conversation on what's ahead for the U.S. retailer.
Improving economic data, wider market volume and Trump administration policy expectations are pushing stocks, Mohamed El-Erian says.
The "FANG" stocks could outperform the market by more than 30 percent this year, forecasts the well-known market watcher.
A daily look at the morning's key financial stories.
Some of the names on the move ahead of the open.
Citi Research forecasts Square can grow its sales by 29 percent annually through 2019.
UnitedHealth denies allegations it gamed the nation's Medicare system for hundreds of millions of dollars.
Fundstrat says the Facebook, Amazon, Netflix and Google-parent Alphabet stocks basket now has a value of $1.3 trillion.
Kraft Heinz's proposed Unilever merger marks another consolidation effort in the food industry by 3G Capital and Warren Buffett's Berkshire Hathaway.
Jefferies says Arch Coal can generate enough cash in the next five years to equal nearly 70 percent of its current market value.
Citi Research barometer declined on Thursday after weaker-than-expected data.
Piper Jaffray expects strong fourth-quarter financial results from Workday due to "marquee signings."
A top tech analyst shares his best three picks in the space, which include Facebook and Amazon, and he discusses trends to watch in 2017.
Get the best of CNBC in your inbox